A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism
Tài liệu tham khảo
Barbieri, 1990, Hyperandrogenic disorders, Clin Obstet Gynecol, 33, 640, 10.1097/00003081-199009000-00028
Knochenhauer, 1995, Advances in the diagnosis and treatment of the hirsute patient, Curr Opin Obstet Gynecol, 7, 344, 10.1097/00001703-199510000-00004
Gregoriou, 2008, Treatment of hirsutism with combined pill containing drospirenone, Gynecol Endocrinol, 24, 220, 10.1080/09513590801948309
Oláh, 2004, The modern management of hirsutism, Rev Gynaecol Practise, 4, 211, 10.1016/j.rigp.2004.05.001
Murphy, 1990, Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women, Fertil Steril, 53, 35, 10.1016/S0015-0282(16)53212-9
Azziz, 2003, The evaluation and management of hirsutism, Obstet Gynecol, 101, 995, 10.1016/S0029-7844(02)02725-4
Krattenmacher, 2000, Drospirenone: pharmacology and pharmacokinetics of unique progestogen, Contraception, 62, 29, 10.1016/S0010-7824(00)00133-5
van Vloten, 2002, The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea, Cutis, 69, 2
Thorneycroft, 2004, Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment, Cutis, 74, 123
Batukan, 2006, Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism, Fertil Steril, 85, 436, 10.1016/j.fertnstert.2005.07.1311
Kriplani, 2010, Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome, Contraception, 82, 139, 10.1016/j.contraception.2010.02.009
Bachmann, 2004, Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone, Contraception, 70, 191, 10.1016/j.contraception.2004.05.013
Pearlstein, 2005, Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation, Contraception, 72, 414, 10.1016/j.contraception.2005.08.021
Koltun, 2008, Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial, Contraception, 77, 249, 10.1016/j.contraception.2007.11.003
Homburg, 2002, What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome, Hum Reprod, 17, 2495, 10.1093/humrep/17.10.2495
Hatch, 1981, Hirsutism: implications, etiology, and management, Am J Obstet Gynecol, 140, 815, 10.1016/0002-9378(81)90746-8
Blode, 2000, A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers, Eur J Contracept Reprod Health Care, 5, 256, 10.1080/13625180008500407
Guido, 2004, Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study, J Clin Endocrinol Metab, 89, 2817, 10.1210/jc.2003-031158
Sulak, 2002, Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms, Am J Obstet Gynecol, 186, 1142, 10.1067/mob.2002.122988
Keam, 2003, Ethinylestradiol/drospirenone: a review of its use as an oral contraceptive, Treat Endocrinol, 2, 49, 10.2165/00024677-200302010-00005
Batukan, 2007, Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism, Gynecol Endocrinol, 23, 38, 10.1080/09637480601137066
Bruni Bresciani, 2010, Extracontraceptive benefits of EE/DRSP (Yaz) in 24+4 day regimen, Minerva Ginecol, 62, 261
Cremer, 2010, Recent innovations in oral contraception, Semin Reprod Med, 28, 140, 10.1055/s-0030-1248139